Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
17 October 2022
Closing Date:
18 November 2022
Location(s):
PL84 Podlaskie (PL Poland/POLSKA)
Description:
“Supply of pharmaceutical products to the Public Health Care Department in Siemiatycze”

1. The subject of the contract is the delivery of medicines, hereinafter referred to as THE SWZ: goods, for the Independent Public Health Care Institution in Siemiatycze, hereinafter referred to as the Ordering Party, in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ – Assortment and quantity form. 2. A detailed description of the subject of the contract, a list of the required limit parameters covered by the delivery listed in paragraph 1 shall include an assortment and quantity form with a description, constitute Annex 1 to the SWZ in detailed parts of packages from 1 to 164 to the offer, constituting an integral part of it, and then an integral part of the delivery contract. The data (parameters) mentioned in the subject of the contract and any indications concerning the device (components) should be understood as defining technical parameters or quality standards. 3. The quantity of goods specified in the SWZ, intended for purchase during the term of the contract, has been determined in an estimated manner. The quantity of goods purchased by the Ordering Party during the term of the Agreement may be smaller and the Contractor shall not be entitled to any claims against the Ordering Party, provided that the Ordering Party acquires goods with a value not lower than 60% of the total net value of the Agreement specified in § 4 section 1. (model contract) In the case specified in the previous sentence, the Contractor is entitled to remuneration only for properly performed deliveries in accordance with the Agreement.

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Supply of pharmaceutical products in the quantity and assortment and with the parameters specified in Annex 1 to the SWZ

Download full details as .pdf
The Buyer:
Samodzielny Publiczny Zakład Opieki Zdrowotnej w Siemiatyczach
CPV Code(s):
33141540 - Albumin
33600000 - Pharmaceutical products
33612000 - Medicinal products for functional gastrointestinal disorders
33613000 - Laxatives
33614000 - Antidiarrhoeals, intestinal anti-inflammatory/anti-infective agents
33615100 - Insulin
33616000 - Vitamins
33617000 - Mineral supplements
33621000 - Medicinal products for the blood and blood-forming organs
33621100 - Antithrombotic agents
33621200 - Antihaemorrhagics
33622000 - Medicinal products for the cardiovascular system
33622200 - Antihypertensives
33622300 - Diuretics
33622400 - Vasoprotectives
33631000 - Medicinal products for dermatology
33631400 - Antibiotics and chemotherapeutics for dermatological use
33640000 - Medicinal products for the genitourinary system and hormones
33642200 - Corticosteroids for systemic use
33642300 - Thyroid therapy medicinal products
33651100 - Antibacterials for systemic use
33651200 - Antimycotics for systemic use
33651400 - Antivirals for systemic use
33651600 - Vaccines
33661000 - Medicinal products for the nervous system
33661100 - Anaesthetics
33661200 - Analgesics
33661300 - Antiepileptics
33662100 - Ophthalmologicals
33670000 - Medicinal products for the respiratory system
33675000 - Antihistamines for systemic use
33690000 - Various medicinal products
33692100 - Infusion solutions
33692200 - Parenteral nutrition products
33692500 - Injectable solutions
33692510 - Intravenous fluids
33694000 - Diagnostic agents
33696000 - Reagents and contrast media